Pulmonx Corporation
Pulmonx Corporation (NASDAQ: LUNG) is trading at $1.98, about ₹190 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, up 1.02% today. Indian residents can buy Pulmonx from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$1.95
Today's high
$2.00
52 week low
$1.13
52 week high
$2.89
LUNG opened at $1.98, closed previously at $1.96, and has traded between $1.13 and $2.89 over the past 52 weeks.
About
Pulmonx Corporation is a biomedical technology firm dedicated to developing and commercializing advanced, less invasive devices for managing chronic obstructive pulmonary diseases. Its primary offering, the Zephyr Endobronchial Valve, is specifically engineered to treat bronchoscopic hyperinflation in adults afflicted with severe emphysema. Complementing its therapeutic solutions, the company also provides the Chartis Pulmonary Assessment System. This system features a specialized balloon catheter and console, fitted with flow and pressure sensors, which is instrumental in evaluating the presence of collateral ventilation in patients. Additionally, Pulmonx offers the StratX Lung Analysis Platform, a cloud-based service that conducts quantitative computed tomography (CT) analysis. This platform delivers vital data concerning emphysema destruction, fissure completeness, and lobar volume, thereby aiding clinicians in accurately identifying the most suitable target lobes for treatment with Zephyr Valves. Pulmonx serves emphysema patients across a broad international footprint, encompassing the United States, Europe, the Middle East, Africa, and the Asia-Pacific region. The company, which changed its name from Pulmonx to Pulmonx Corporation in December 2013, was originally incorporated in 1995 and maintains its corporate headquarters in Redwood City, California.
Key statistics
Avg. volume
498.71K
Market cap
$83.63M
P/E Ratio
-1.72
Price-to-sales ratio
0.96
Enterprise value
$76.27M
Free cash flow yield
-36.59%
Debt-to-equity ratio
1.43
Return on equity
-99.79%
ROIC
-48.54%
Beta
0.28
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$90.50M
Earnings per share
-$1.33
Free cash flow
-$32.90M
Net profit margin
-55.03%
Gross margin
77.06%
EBITDA
-$49.17M
Revenue growth
8.01%
Similar securities
This is not an investment recommendation
How to buy Pulmonx from India
Indian residents can buy Pulmonx shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Pulmonx and place an order
Find Pulmonx by name or by its ticker, LUNG, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Pulmonx trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Pulmonx position in USD and INR. Pulmonx pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Pulmonx from India
Trading and taxes when buying Pulmonx from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NonePulmonx does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Pulmonx stock?
Yes. Pulmonx (LUNG) has been listed on NASDAQ since 2020, in the Medical - Devices industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Pulmonx share cost in rupees?
One Pulmonx share is $1.98 — about ₹190 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Pulmonx price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Pulmonx from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Pulmonx?
Yes. One Pulmonx share is $1.98, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Pulmonx.
How are gains on Pulmonx shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Pulmonx price. Paasa issues a capital-gains statement for your return.
Does Pulmonx pay a dividend?
No. Pulmonx does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Pulmonx from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Pulmonx shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Pulmonx shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Pulmonx holding, its cost and its closing value.
How do I sell Pulmonx and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.